The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?

The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?

Background: MS is a highly heterogeneous disease, both in its course and in its response to treatments. Effective biomarkers may help predict disability progression and monitor patients’ treatment responses. <br/>Objective: To focus on how biomarkers may contribute to treatment individualisat...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Vermersch, P, Berger, T, Gold, R, Lukas, C, Rovira, A, Meesen, B, Chard, D, Comabella, M, Palace, J, Trojano, M
פורמט: Journal article
שפה:English
יצא לאור: SAGE Publications 2016

פריטים דומים

פריטים דומים